Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4824-4833

  Doyle, Hester A ^a,b   Murphy, Juneann W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE; GELATIN SPONGE; IMMUNOGLOBULIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DELAYED HYPERSENSITIVITY; EOSINOPHIL; FEMALE; GRANULOCYTE; LIVER; LUNG; LYMPHOCYTE; MACROPHAGE; MODEL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CELL MOVEMENT; CHEMOKINES, CC; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; FEMALE; GELATIN SPONGE, ABSORBABLE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; KINETICS; LEUKOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED CBA; NEUTROPHILS; RECOMBINANT PROTEINS;

EID: 0033561764     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kwon-Chung, K. J. 1992. Cryptococcosis. In Medical Mycology. K. J. Kwon-Chung and J. E. Bennet, eds. Lea & Febiger, Philadelphia, p. 397.
2. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515.
3. Cauley, L. K., and J. W. Murphy. 1979. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun. 23:644.
4. Graybill, J. R., and D. J. Drutz. 1978. Host defense in cryptococcosis in the nude mouse. Cell. Immunol. 40:263.
5. Nishimura, K., and M. Miyaji. 1979. Histopathological studies on experimental cryptococcosis in nude mice. Mycopathologia 68:145.
6. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423.
7. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
8. + T cells. J. Exp. Meet. 173:755.
9. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685.
10. + T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J. Immunol. 152:2344.
11. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472.
12. Yuan, R. R., A. Casadevall, J. Oh, and M.D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94:2483.
13. Miller, M. F., and T. G. Mitchell. 1991. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:24.
14. Chaturvedi, V., B. Wong, and S. L. Neuman. 1996. Oxidative killing of Cryptococcus neoformans by human neutrophils: evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J. Immunol. 156:3886.
15. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529.
16. Huffnagle, G. B., G. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507.
17. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487.
18. Rollins, B. J. 1997. Chemokines. Blood 90:909.
19. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokines. Science 266:1395.
20. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141:1018.
21. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur. J. Immunol. 25:751.
22. Wilson, S. D., P. R. Burd, P. R. Billings, C. A. Martin, and M. E. Dorf. 1988. The expression and regulation of a potential lymphokine gene (TCA3) in CD4 and CD8 T cell clones. J. Immunol. 141:1563.
23. Luo, Y., J. Laning, S. Devi, J. Mak, T. J. Schall, and M. E. Dorf. 1994. Biologic activities of the murine β-chemokine TCA3. J. Immunol. 153:4616.
24. Devi, S., J. Laning, Y. Luo, and M. E. Dorf. 1995. Biologic activities of the β-chemokine TCA3 on neutrophils and macrophages. J. Immunol. 154:5376.
25. Buchanan, K. L., and J. W. Murphy. 1993. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:2854.
26. Buchanan, K. L., and J. W. Murphy. 1997. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 90:189.
27. Murphy, J. W. 1998. Protective cell-mediated immunity against Cryptococcus neoformans. Res. Immunol. 149:373.
28. Goust, J., and B. Bierer. 1993. Cell-mediated immunity. Immunol. Ser. 58:187.
29. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and R. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Chem. 28:350.
30. Lim, T. S., J. W. Murphy, and L. K. Cauley. 1980. Host-etiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice. Infect. Immun. 29:633.
31. Dong, Z. M., and J. W. Murphy. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63:770.
32. Wilson, S. D., V. K. Duchroo, D. I. Israel, and M. E. Dorf. 1990. Expression and characterization of TCA3: a murine inflammatory protein. J. Immunol. 145:2745.
33. Doyle, H. A., and J. W. Murphy. 1997. MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukocyte Biol. 61:147.
34. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652.
35. + T lymphocytes. FASEB J. 8:1055.
36. Taub, D. D., A. R. Lloyd, J. Wang, J. J. Oppenheim, and D. J. Kelvin. 1993. The effects of human recombinant MIP-1α, MIP-1β, and RANTES on the chemotaxis and adhesion of T cell subsets. In The Chemokines. I. J. D. Lindley, ed. Plenum Press, New York, p. 139.
37. Schall, T. J., K. Bacon, R. D. R. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein-1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821.
38. Rand, M. L., J. S. Warren, M. K. Mansour, W. Newman, and D. J. Ringler. 1996. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am. J. Pathol. 148:855.
39. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155: 4790.
40. Siveke, J. T., and A. Hamann. 1998. Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:550.
41. Kasama, T., R. M. Strieter, T. J. Standiford, M. D. Burdick, and S. L. Kunkel. 1993. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1α. J. Exp. Med. 178:63.
42. McColl, S. R., C. J. Roberge, B. Larochelle, and J. Gosselin. 1997. EBV induces the production and release of IL-8 and macrophage inflammatory protein-1α in human neutrophils. J. Immunol. 159:6164.
43. VanOtteren, G. M., T. J. Standiford, S. L. Kunkel, J. M. Danforth, M. D. Burdick, L. V. Abruzzo, and R. M. Strieter. 1994. Expression and regulation of macrophage inflammatory protein-1α by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell Mol. Biol. 10:8.
44. + T cells in response to MIP-1α and MIP-1β. Science 260:355.
45. Huffnagle, G. B., R. M. Strieter, L. K. McNeil, R. A. McDonald, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1997. Macrophage inflammatory protein-1α (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318.
46. Dong, Z. M., and J. W. Murphy. 1993. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61:5067.
47. Fung, P. Y. S., and J. W. Murphy. 1982. In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infect. Immun. 36:1128.
48. Muth, S. M., and J. W. Murphy. 1995. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice, Infect. Immun 63: 1637.
49. Murphy, J. W. 1996. Cell-mediated immunity. In The Mycota VI Human and Animal Relationships. D. H. Howard and J. D. Miller, eds. Springer-Verlag. Berlin, p. 67.
50. Murphy, J. W., F. Schafer, A. Casadevall, and A. Adesina. 1998. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infect. Immun. 66:2632.
51. Godiska, R., D. Chantry, G. N. Dietsch, and P. W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167.